📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
HOMECOVERAGENRXP › EARNINGS
EARNINGS HUB
News Coverage Earnings Hub Earnings Report Grades
$NRXP
NRXP Earnings: Miss 0/4 · 4 quarters tracked
LAST 30 DAYS
1 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
TOTAL VIEWS
19
◈ EARNINGS HUB · 2026-06

NRXP Earnings: Miss, Surprise History & Forecast

0/4 quarters beaten · Last EPS $-0.44 (+-773.8%) · AI Grade: NEUTRAL
◈ ESEN AI · EARNINGS PREVIEW
NRXP reported EPS of $-0.44 in its most recent quarter (2026-06), missing consensus estimate of $0.07 by -773.8%. Over the last 4 quarters, the company has beaten estimates 0 times (0% beat rate) with an average surprise of +-431.4%. ESEN AI grade: NEUTRAL.
LAST EPS
$-0.44
est $0.07
LAST SURPRISE
-773.8%
2026-06
BEAT RATE
0/4
beats / quarters
AVG SURPRISE
-431.4%
last 4Q
◆ EPS MOMENTUM
PERIOD
ACTUAL EPS
ESTIMATE
SURPRISE
2026-06-30
$-0.44
$0.07
-773.8%
2026-03-31
$-0.04
$0.29
-113.6%
2025-12-31
$-0.01
$-0.00
-361.5%
2025-09-30
$-0.50
$-0.09
-476.7%
◈ RELATED EARNINGS NEWS
seekingalpha
2026-08-10
NRx Pharmaceuticals, Inc. (NRXP) Discusses FDA First Cycle Review Outcome and Commercialization Plans for Preservative Free Ketamine Transcript
LOW
insidermonke
2026-07-15
Is NRx Pharmaceuticals, Inc. (NRXP) Stock Positioned for Growth Through Depression and PTSD Treatment Innovation?
NEUTRAL
View all NRXP news →
◈ FREQUENTLY ASKED QUESTIONS
When did $NRXP last report earnings?
NRXP last reported earnings on 2026-06-30, with actual EPS of $-0.44 vs estimate of $0.07.
Did $NRXP beat earnings estimates?
No, NRXP missed consensus EPS by -773.8%.
What is $NRXP's earnings beat rate?
NRXP has beaten consensus EPS in 0 of 4 quarters (0%). Average surprise: +-431.4%.
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours. Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice